Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FTO | Q9C0B1 | 1/20 | 1.00 |
| ▸ | MAPT | P10636 | 9/20 | 0.66 |
| ▸ | L3MBTL1 | Q9Y468 | 6/20 | 0.66 |
| ▸ | NPC1 | O15118 | 6/20 | 0.66 |
| ▸ | RAB9A | P51151 | 6/20 | 0.66 |
| ▸ | MAPK1 | P28482 | 5/20 | 0.66 |
| ▸ | CASP3 | P42574 | 1/20 | 0.64 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.64 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.64 |
| ▸ | THRB | P10828 | 1/20 | 0.59 |
| ▸ | NQO2 | P16083 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.52 |
| ▸ | MEN1 | O00255 | 7/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.51 |
| ▸ | POLB | P06746 | 3/20 | 0.51 |
| ▸ | GAA | P10253 | 3/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.51 |
| ▸ | HSP90AA1 | P07900 | 3/20 | 0.50 |
| ▸ | MPL | P40238 | 1/20 | 0.50 |
| ▸ | CCR6 | P51684 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1275967 | 1.00 | FTO (1.00) | FTOMAPTL3MBTL1NPC1RAB9A | |
| SCHEMBL23511143 | 0.89 | FTO (0.79) | FTOMAPTL3MBTL1NPC1RAB9A | |
| SCHEMBL12565720 | 0.89 | FTO (0.79) | FTOMAPTL3MBTL1NPC1RAB9A | |
| SCHEMBL7913514 | 0.86 | NPC1 (0.80) | FTOMAPTL3MBTL1NPC1RAB9A | |
| SCHEMBL8204503 | 0.86 | NPC1 (0.80) | FTOMAPTL3MBTL1NPC1RAB9A | |
| SCHEMBL15214125 | 0.85 | FTO (0.74) | FTOMAPTL3MBTL1NPC1RAB9A | |
| SCHEMBL11305360 | 0.85 | FTO (0.73) | FTOMAPTL3MBTL1NPC1RAB9A | |
| SCHEMBL11305364 | 0.85 | FTO (0.73) | FTOMAPTL3MBTL1NPC1RAB9A | |
| SCHEMBL9148461 | 0.84 | FTO (0.72) | FTOMAPTL3MBTL1NPC1RAB9A | |
| SCHEMBL9148464 | 0.84 | FTO (0.72) | FTOMAPTL3MBTL1NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12024549-B2 | Compound having affinity substance to soluble protein, cleavable portion and reactive group, or salt thereof | AJINOMOTO CO., INC. (JP) | 2024-07-02 | — | — | US | disclosed |
| US-11873359-B2 | Photocurable composition, three-dimensional molded product, and dental product | MITSUI CHEMICALS, INC. (JP) | 2024-01-16 | — | — | US | disclosed |
| US-11873359-B2 | Photocurable composition, three-dimensional molded product, and dental product | MITSUI CHEMICALS, INC. (JP) | 2024-01-16 | — | — | US | disclosed |
| US-20210300972-A1 | COMPOUND HAVING AFFINITY SUBSTANCE TO ANTIBODY, CLEAVABLE PORTION, AND REACTIVE GROUP, OR SALT THEREOF | AJINOMOTO CO., INC. (JP) | 2021-09-30 | — | — | US | disclosed |
| US-20170175017-A1 | METHOD OF MAKING HYDROCARBON LIQUIDS | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2017-06-22 | — | — | US | disclosed |
| US-9650538-B2 | Method for manufacturing micro-structure | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2017-05-16 | — | — | US | disclosed |
| US-9625440-B2 | Method of marking hydrocarbon liquids | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2017-04-18 | — | — | US | disclosed |
| US-9606435-B2 | Method for manufacturing micro-structure and optically patternable sacrificial film-forming composition | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2017-03-28 | — | — | US | disclosed |
| US-9557664-B2 | Electrophotographic photosensitive member, method for manufacturing the same, process cartridge, and electrophotographic apparatus | CANON KABUSHIKI KAISHA (JP) | 2017-01-31 | — | — | US | disclosed |
| US-9557664-B2 | Electrophotographic photosensitive member, method for manufacturing the same, process cartridge, and electrophotographic apparatus | CANON KABUSHIKI KAISHA (JP) | 2017-01-31 | — | — | US | disclosed |
| WO-2011020928-A2 | PHOTORESPONSIVE SUNSCREEN COMPOSITION | BLUESHIFT PHARMA GMBH (CH) | 2011-02-24 | — | — | WO | disclosed |
| US-7708396-B2 | Photochromic phase change inks | XEROX CORPORATION (US) | 2010-05-04 | — | — | US | disclosed |
| US-20070211124-A1 | PHOTOCHROMIC PHASE CHANGE INKS | XEROX CORPORATION (US) | 2007-09-13 | — | — | US | disclosed |
| US-7022331-B2 | Thermochromic/photochromic cosmetic compositions | Theisen, Lyle (US) | 2006-04-04 | — | — | US | disclosed |
| US-20020192247-A1 | Thermochromic/photochromic cosmetic compositions | THEISEN LYLE (US) | 2002-12-19 | — | — | US | disclosed |
| US-5759729-A | A DRY TONER COMPRISING A RESIN, PHOTOCHROMATIC SPIROPYRAN, -OXAZINE OR -THIOPYRAN DYE AND A CHARGE CONTROL AGENT;ELECTROGRAPHY; XEROGRAPHY | XEROX CORPORATION (US) | 1998-06-02 | — | — | US | disclosed |
| US-5710420-A | Method for embedding and recovering machine-readable information | XEROX CORPORATION (US) | 1998-01-20 | — | — | US | disclosed |
| US-5633109-A | Ink compositions with liposomes containing photochromic compounds | XEROX CORPORATION (US) | 1997-05-27 | — | — | US | disclosed |
| US-5593486-A | Photochromic hot melt ink compositions | XEROX CORPORATION (US) | 1997-01-14 | — | — | US | disclosed |
| US-5551973-A | LIQUID CRYSTAL GEL PHASE, MICROEMULSION PHASE | XEROX CORPORATION (US) | 1996-09-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12024549-B2 | Compound having affinity substance to soluble protein, cleavable portion and reactive group, or salt thereof | SPPL2B, CSTB, SPPL2A | FTO 4457/4885MAPT 4288/4885L3MBTL1 2461/4885 |
| US-11873359-B2 | Photocurable composition, three-dimensional molded product, and dental product | F9, TAS2R9, TAS1R1 | FTO 2099/4885MAPT 180/4885L3MBTL1 4569/4885 |
| US-20210300972-A1 | COMPOUND HAVING AFFINITY SUBSTANCE TO ANTIBODY, CLEAVABLE PORTION, AND REACTIVE GROUP, OR SALT THEREOF | FCGR3B, FCGR2A, QPCTL | FTO 4276/4885MAPT 3657/4885L3MBTL1 1072/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.